XELODA Special Drug Use Surveillance, XELOX as adjuvant chemotherapy for colon cancer
Not Applicable
- Conditions
- colon cancer
- Registration Number
- JPRN-UMIN000016446
- Lead Sponsor
- Chugai Pharmaceutical Co. Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patients <65 years old when starting XELOX therapy 2) Patients without serum creatinine data before XELOX therapy 3) Patients who did not start XELOX therapy at the specified initial dose 4) Patients with other cancers
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ADR incidence according to creatinine clearance rate before XELOX
- Secondary Outcome Measures
Name Time Method Early, 4 cycles, withdrawal of XELOX according to creatinine clearance rate before XELOX